724 results on '"Guan, Xin-Yuan"'
Search Results
2. HSPA4 upregulation induces immune evasion via ALKBH5/CD58 axis in gastric cancer
3. LOXL1 promotes tumor cell malignancy and restricts CD8 + T cell infiltration in colorectal cancer
4. SPINK1-induced tumor plasticity provides a therapeutic window for chemotherapy in hepatocellular carcinoma
5. Fibroblasts in metastatic lymph nodes confer cisplatin resistance to ESCC tumor cells via PI16
6. Blockade of NMT1 enzymatic activity inhibits N-myristoylation of VILIP3 protein and suppresses liver cancer progression
7. Nasopharyngeal carcinoma cells promote regulatory T cell development and suppressive activity via CD70-CD27 interaction
8. PPM1G promotes cell proliferation via modulating mutant GOF p53 protein expression in hepatocellular carcinoma
9. Author Correction: Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
10. GLIPR1 promotes proliferation, metastasis and 5-fluorouracil resistance in hepatocellular carcinoma by activating the PI3K/PDK1/ROCK1 pathway
11. Optimal time for early therapeutic response prediction in nasopharyngeal carcinoma with functional magnetic resonance imaging
12. Ferroptosis: Promising approach for cancer and cancer immunotherapy
13. The Origin, Differentiation, and Functions of Cancer-Associated Fibroblasts in Gastrointestinal Cancer
14. Roles of heat shock proteins in tumor immune microenvironment
15. A T cell resilience model associated with response to immunotherapy in multiple tumor types
16. Peritumoral B cells drive proangiogenic responses in HMGB1-enriched esophageal squamous cell carcinoma
17. Long non-coding RNA NEAT1 mediated RPRD1B stability facilitates fatty acid metabolism and lymph node metastasis via c-Jun/c-Fos/SREBP1 axis in gastric cancer
18. PITX2C increases the stemness features of hepatocellular carcinoma cells by up-regulating key developmental factors in liver progenitor
19. Targeting TROY-mediated P85a/AKT/TBX3 signaling attenuates tumor stemness and elevates treatment response in hepatocellular carcinoma
20. HN1L/AP-2γ/PLK1 signaling drives tumor progression and chemotherapy resistance in esophageal squamous cell carcinoma
21. Potential synthetic lethality for breast cancer: A selective sirtuin 2 inhibitor combined with a multiple kinase inhibitor sorafenib
22. Identification and Characterization of Metastasis‐Initiating Cells in ESCC in a Multi‐Timepoint Pulmonary Metastasis Mouse Model.
23. Elevated expression of RIT1 hyperactivates RAS/MAPK signal and sensitizes hepatocellular carcinoma to combined treatment with sorafenib and AKT inhibitor
24. Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
25. A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets
26. PGC7 promotes tumor oncogenic dedifferentiation through remodeling DNA methylation pattern for key developmental transcription factors
27. DAPK3 inhibits gastric cancer progression via activation of ULK1-dependent autophagy
28. C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
29. Correction: C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism
30. Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma
31. PARP inhibitor Olaparib overcomes Sorafenib resistance through reshaping the pluripotent transcriptome in hepatocellular carcinoma
32. Correction to: CircLONP2 enhances colorectal carcinoma invasion and metastasis through modulating the maturation and exosomal dissemination of microRNA-17
33. Comprehensive single-cell sequencing reveals the stromal dynamics and tumor-specific characteristics in the microenvironment of nasopharyngeal carcinoma
34. RALYL increases hepatocellular carcinoma stemness by sustaining the mRNA stability of TGF-β2
35. Genome-wide identification of key regulatory lncRNAs in esophageal cancer metastasis
36. Molecular subclassification of gastrointestinal cancers based on cancer stem cell traits
37. Publisher Correction: A T cell resilience model associated with response to immunotherapy in multiple tumor types
38. HOXC10 upregulation confers resistance to chemoradiotherapy in ESCC tumor cells and predicts poor prognosis
39. Chromosomal translocation-derived aberrant Rab22a drives metastasis of osteosarcoma
40. Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model
41. Nuclear DLC1 exerts oncogenic function through association with FOXK1 for cooperative activation of MMP9 expression in melanoma
42. HN1L-mediated transcriptional axis AP-2γ/METTL13/TCF3-ZEB1 drives tumor growth and metastasis in hepatocellular carcinoma
43. CHD1L augments autophagy-mediated migration of hepatocellular carcinoma through targeting ZKSCAN3
44. Membrane Metalloendopeptidase (MME) Suppresses Metastasis of Esophageal Squamous Cell Carcinoma (ESCC) by Inhibiting FAK-RhoA Signaling Axis
45. TROP-2 exhibits tumor suppressive functions in cervical cancer by dual inhibition of IGF-1R and ALK signaling
46. ApoA-1 accelerates regeneration of small-for-size fatty liver graft after transplantation
47. A neural‐related gene risk score for head and neck squamous cell carcinoma.
48. Expansion of cancer stem cell pool initiates lung cancer recurrence before angiogenesis
49. Overexpression of MUC13, a Poor Prognostic Predictor, Promotes Cell Growth by Activating Wnt Signaling in Hepatocellular Carcinoma
50. Correction: Overexpression of maelstrom promotes bladder urothelial carcinoma cell aggressiveness by epigenetically down-regulating MTSS1 through DNMT3B
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.